INDIA
40 patients suffering from new Covid strain admitted to LNJP
Talking about the current situation in the capital, Delhi's Health Minister Satyendar Jain said on Saturday that the positivity rate in Delhi was 0.73 per cent and is steadily declining as only 585 new cases were reported in Delhi on Friday. "We hope that the number of new cases in Delhi remain below 500," he added.
Bharat Biotech recruits 23,000 volunteers for Phase III trials of Covaxin
The phase-III human clinical trials of Covaxin began mid-November, targeting 26,000 volunteers across India. This is India's first and only phase III efficacy study for a Covid-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India, the Hyderabad-based company said.
CDS Gen Rawat visits forward air bases in Arunachal
Complimenting the soldiers for the innovative measures adopted to maintain effective surveillance and enhanced operational readiness, he said that only Indian soldiers could remain vigilant under such challenging situations and they are ever willing to go well beyond the call of duty to safeguard the borders. "Nothing can deter the Indian armed forces on remaining steadfast in their call for duty," he said.
Lalu indulging in political manipulations from jail: Sushil Modi
Sushil Kumar Modi also took a dig at the Rashtriya Janata Dal, saying that those who had made transfers and postings a source of income when in power in Bihar want to give political colours to routine administrative work due to dried-up avenues of earning money on the sly.
Airtels says Jio's allegations 'baseless', condemns tower damage
In a letter to the Anshu Prakash, Secretary of Department of Telecommunications, Airtel also condemned the disruption of telecom networks and the instances of vandalism. It also said that Jio's annexure to the complaint did not demonstrate any evidence that Airtel has hand in the ongoing issues faced by Jio.
Farmer impasse likely to be resolved on Monday
The government may well be ready to offer amendments to the MSP and APMC issues in writing. As per the government and farmer sources, Monday will see a big breakthrough after more than six rounds of talks between the two parties have been held. The sticking points of MSP being retained and APMC may well see a resolution.
Government making efforts for equal attention to all security aspects: Amit Shah
The Minister expressed his views after releasing an inaugural issue of "National Police K-9 Journal" here. It is first such publication in the country on Police Service K9s (PSKs) or police dogs. "National security is paramount and our government is making sincere efforts to give equal attention to all aspects related to security. The police dog squad can act as a force multiplier to ensure the safety of society, much like the way drones or satellites are used in the country," Shah said.
Goa Shipyard to build 12 patrol boats for Pangong deployment
The PSU is expected to roll out the patrol boats by May 2021, by when snow would have melted at the lake and a face-off between India and China troops could resume. The Defence sector Public Sector Undertaking will also carry out maintenance of these boats for four years.
India successfully cultures UK coronavirus variant: ICMR
The British Government had recently announced that the newly identified strain of the virus found in their population is up to 70 per cent more transmissible, following which India sprung into action. The country put in place a pro-active and preventive strategy to detect and contain the variant. So far, the new variant has been detected in 29 UK returnees through genome sequencing.
After 'Covishield', expert panel recommends Bharat Biotech's 'Covaxin' for emergency use
The committee of experts assessing Coronavirus vaccines had called Hyderabad-based Bharat Biotech for a meeting in the afternoon today, a day after the firm was asked to present more data to get a nod, a top source said on Saturday. On Friday, the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) had held that the data provided by Bharat Biotech for its Coronavirus vaccine is not sufficient for grant of emergency use approval and asked for more information.
Don't Miss
Advertisement